Constance A. Wilkinson
CMS Names Its First Ten Negotiated Part D Drugs: Inflation Reduction Act Updates
Health Care and Life Sciences ·
More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate
Health Care and Life Sciences ·
Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023
Health Care and Life Sciences ·